These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS. Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
5. The cardiac arrhythmia suppression trial (CAST). Ruskin JN. N Engl J Med; 1989 Aug 10; 321(6):386-8. PubMed ID: 2501683 [No Abstract] [Full Text] [Related]
7. [Anti-arrhythmia agents following a myocardial infarct: the results of the CAST study. Cardiac Arrhythmia Suppression Trial]. Hohnloser S. Dtsch Med Wochenschr; 1991 Jul 26; 116(30):1166-7. PubMed ID: 1855450 [No Abstract] [Full Text] [Related]
9. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?]. Naccarella F, Croci F. G Ital Cardiol; 1996 Nov 26; 26(11):1345-64. PubMed ID: 9036037 [No Abstract] [Full Text] [Related]
18. [Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction]. Coumel P. Arch Mal Coeur Vaiss; 1990 Sep 26; 83(10):1497-9. PubMed ID: 1978650 [No Abstract] [Full Text] [Related]
19. Sudden cardiac death, ventricular arrhythmias, and antiarrhythmic therapy: current trials and tribulations. Anderson JL. Aust N Z J Med; 1986 Jun 26; 16(3):409-12. PubMed ID: 3535769 [No Abstract] [Full Text] [Related]